Discover the most oversold healthcare stocks for Q1 earnings week 2 using RSI signals—ABT, JNJ, GILD and more.
Looking at the universe of stocks we cover at Dividend Channel, on 4/15/25, Buckle, Inc. (Symbol: BKE), AbbVie Inc (Symbol: ABBV), and Abbott Laboratories (Symbol: ABT) will all trade ex-dividend for ...
Abbott Laboratories (ABT) kicked off Q1 2026 earnings season with a mixed report, where revenue grew ~8% year-over-year to $11.2 billion, beating the consensus by $160 million, driven primarily by a ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
ABBOTT LABORATORIES insiders have traded $ABT stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales ...
Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue in the third quarter ended Sept. 30 rose 6.9% to ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Abbott Laboratories Inc. pleaded guilty and agreed to pay $1.5 billion to resolve allegations that it illegally promoted the drug Depakote. The development highlights the risk of investing in managers ...
Three years after the U.S. FDA approval of Abbott Laboratories’ Amplatzer Amulet, results of its investigational device exemption trial failed to notably differentiate Abbott’s left atrial appendage ...
NEW YORK (Reuters) - Abbott Laboratories Inc said on Friday that it could have a shorter duration combination therapy for hepatitis C on the market in 2015 with annual sales potential of about $2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results